A novel polypeptide extracted from Ciona savignyi induces apoptosis through a mitochondrial-mediated pathway in human colorectal carcinoma cells. 2012

Linyou Cheng, and Chunguang Wang, and Haizhou Liu, and Fengxia Wang, and Lanhong Zheng, and Jin Zhao, and Edward Chu, and Xiukun Lin
Institute of Oceanology, Chinese Academy of Sciences, Qingdao, China.

BACKGROUND Sessile marine animals such as sponges, ascidians, and bryozoans are a rich source of bioactive natural products, many of which exhibit potent anticancer activity. METHODS We extracted and purified a polypeptide with potent antitumor activity from Ciona savignyi by acetone fractionation, ultrafiltration, ion exchange chromatography, gel chromatography, and high-performance liquid chromatography. An MTT assay was used to study the cytotoxicity of the isolated fraction and the purified polypeptide. Cell cycle and Western blot analysis were performed to study the mode of action of the purified polypeptide. RESULTS A novel polypeptide with potent antitumor activity was purified. The molecular weight of the polypeptide, designated CS5931, was 5931 Da, and use of the genome basic local alignment search tool (BLAST) revealed that the N-terminal sequence of CS5931 is identical to that of granulin A from C savignyi. CS5931 exhibited significant cytotoxicity for several cancer cell types and induced apoptotic death in HCT-8 cells in a dose- and time-dependent manner. Cell cycle analysis demonstrated that CS5931 caused cell cycle arrest at the G(2)/M phase, and a sub-G(1) peak appeared after treating the cells with CS5931 for 12 hours. The mitochondrial-mediated pathway was implicated in CS5931-induced apoptosis. CONCLUSIONS Our observations clearly demonstrate the antiproliferative and proapoptotic activities of the polypeptide CS5931 from C savignyi and the mitochondrial-mediated pathway involved in the polypeptide-induced cell death.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077155 Granulins Small, cysteine-rich peptides generated by the proteolytic cleavage of progranulin. Granulin peptides are each composed of a granulin-motif, while paragranulin is composed of a half-granulin motif. The mammalian granulins are named granulin 1-7 for their sequence order in the progranulin propeptide, and are alternately named granulin G, F, B, A, C, D, and E; or epithelin 7, 6, 2, 1, 3, 4, and 5, i.e. granulin 1 aka granulin G aka epithelin 7, etc. Epithelin,Granulin,Epithelin 1,Epithelin 2,Epithelin 3,Epithelin 4,Epithelin 5,Epithelin-1,Epithelin-2,Epithelin2,Epithelins,Granulin (123-179),Granulin (206-261),Granulin 1,Granulin 2,Granulin 3,Granulin 4,Granulin 5,Granulin 6,Granulin 7,Granulin A,Granulin B,Granulin C,Granulin D,Granulin E,Granulin F,Granulin G,Granulin Peptide (281-336),Granulin Peptide (58 -113),Granulin Peptides,Granulin-3,Granulin3,Paragranulin,5, Granulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014561 Urochordata A subphylum of chordates intermediate between the invertebrates and the true vertebrates. It includes the Ascidians. Ascidia,Tunicata,Ascidiacea,Ascidians,Sea Squirts,Tunicates,Urochordates,Ascidian,Sea Squirt,Squirt, Sea,Tunicate,Urochordate
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal

Related Publications

Linyou Cheng, and Chunguang Wang, and Haizhou Liu, and Fengxia Wang, and Lanhong Zheng, and Jin Zhao, and Edward Chu, and Xiukun Lin
February 2016, Food & function,
Linyou Cheng, and Chunguang Wang, and Haizhou Liu, and Fengxia Wang, and Lanhong Zheng, and Jin Zhao, and Edward Chu, and Xiukun Lin
January 2012, Asian Pacific journal of cancer prevention : APJCP,
Linyou Cheng, and Chunguang Wang, and Haizhou Liu, and Fengxia Wang, and Lanhong Zheng, and Jin Zhao, and Edward Chu, and Xiukun Lin
September 2022, Marine drugs,
Linyou Cheng, and Chunguang Wang, and Haizhou Liu, and Fengxia Wang, and Lanhong Zheng, and Jin Zhao, and Edward Chu, and Xiukun Lin
June 2015, Journal of ethnopharmacology,
Linyou Cheng, and Chunguang Wang, and Haizhou Liu, and Fengxia Wang, and Lanhong Zheng, and Jin Zhao, and Edward Chu, and Xiukun Lin
July 2008, Free radical biology & medicine,
Linyou Cheng, and Chunguang Wang, and Haizhou Liu, and Fengxia Wang, and Lanhong Zheng, and Jin Zhao, and Edward Chu, and Xiukun Lin
December 2015, World journal of gastroenterology,
Linyou Cheng, and Chunguang Wang, and Haizhou Liu, and Fengxia Wang, and Lanhong Zheng, and Jin Zhao, and Edward Chu, and Xiukun Lin
January 2020, Journal of oral and maxillofacial pathology : JOMFP,
Linyou Cheng, and Chunguang Wang, and Haizhou Liu, and Fengxia Wang, and Lanhong Zheng, and Jin Zhao, and Edward Chu, and Xiukun Lin
November 2017, Oncology letters,
Linyou Cheng, and Chunguang Wang, and Haizhou Liu, and Fengxia Wang, and Lanhong Zheng, and Jin Zhao, and Edward Chu, and Xiukun Lin
July 2005, Clinical and experimental pharmacology & physiology,
Linyou Cheng, and Chunguang Wang, and Haizhou Liu, and Fengxia Wang, and Lanhong Zheng, and Jin Zhao, and Edward Chu, and Xiukun Lin
September 2011, Molecules (Basel, Switzerland),
Copied contents to your clipboard!